Drug Shortage Report for MAGNESIUM SULFATE INJECTION, USP
| Report ID | 233435 |
| Drug Identification Number | 02139499 |
| Brand name | MAGNESIUM SULFATE INJECTION, USP |
| Common or Proper name | MAGNESIUM SULFATE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | MAGNESIUM SULFATE |
| Strength(s) | 500MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 10 mL |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2024-07-18 |
| Estimated end date | 2024-08-09 |
| Actual end date | 2024-08-09 |
| Shortage status | Resolved |
| Updated date | 2024-08-10 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to unforeseen circumstances, we will be encountering a supply interruption on our Magnesium Sulfate Injection 500 mg/mL SD Vial 10 mL effective July 18, 2024, until August 9, 2024. During this time, our Magnesium Sulfate Injection 500 mg/mL PBP Vial 50 mL is available for substitution. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-08-10 | English | Compare |
| v4 | 2024-08-09 | French | Compare |
| v3 | 2024-08-09 | English | Compare |
| v2 | 2024-07-19 | French | Compare |
| v1 | 2024-07-19 | English | Compare |
Showing 1 to 5 of 5